The estimated Net Worth of David Alan Urbanek is at least 2.84 百万$ dollars as of 18 November 2019. Mr. Urbanek owns over 228 units of Elanco Animal Health Inc stock worth over 1,100$ and over the last 6 years he sold ELAN stock worth over 0$. In addition, he makes 2,839,990$ as Executive Vice President - Manufacturing、 Quality at Elanco Animal Health Inc.
David has made over 2 trades of the Elanco Animal Health Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 228 units of ELAN stock worth 5,987$ on 18 November 2019.
The largest trade he's ever made was buying 500 units of Elanco Animal Health Inc stock on 24 September 2018 worth over 12,000$. On average, David trades about 40 units every 23 days since 2018. As of 18 November 2019 he still owns at least 76 units of Elanco Animal Health Inc stock.
You can see the complete history of Mr. Urbanek stock trades at the bottom of the page.
David A. Urbanek serves as Executive Vice President - Manufacturing, Quality of the Company. Mr. Urbanek served as Vice President of Manufacturing at the Elanco Animal Health division of Lilly from November 2017 to September 2018. Prior to that, Mr. Urbanek served in various leadership roles for Lilly’s Manufacturing division, including Senior Director of Emerging Markets Manufacturing from 2013 to 2017, Senior Director of Global Diabetes Manufacturing from 2011 to 2013, and Senior Director of External Drug Products Operations from 2009 to 2011.
As the Executive Vice President - Manufacturing、 Quality of Elanco Animal Health Inc, the total compensation of David Urbanek at Elanco Animal Health Inc is 2,839,990$. There are 3 executives at Elanco Animal Health Inc getting paid more, with Jeffrey Simmons having the highest compensation of 15,801,800$.
David Urbanek is 53, he's been the Executive Vice President - Manufacturing、 Quality of Elanco Animal Health Inc since 2018. There are 13 older and 14 younger executives at Elanco Animal Health Inc. The oldest executive at Elanco Animal Health Inc is R. David Hoover, 74, who is the Independent Chairman of the Board.
David's mailing address filed with the SEC is C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD, IN, 46140.
Over the last 6 years, insiders at Elanco Animal Health Inc have traded over 1,626,280,000$ worth of Elanco Animal Health Inc stock and bought 657,104 units worth 14,225,149$ . The most active insiders traders include Aktiengesellschaft Bayer Wo...、Scott D.Sachem Head Capital...、R David Hoover. On average, Elanco Animal Health Inc executives and independent directors trade stock every 38 days with the average trade being worth of 14,011,833$. The most recent stock trade was executed by Michael J Harrington on 22 August 2024, trading 3,500 units of ELAN stock currently worth 51,975$.
elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.
Elanco Animal Health Inc executives and other stock owners filed with the SEC include: